ArticleQuantitative imaging in medicine and surgery2026
Diagnostic performance of the main pulmonary artery-to-ascending aorta diameter ratio for pulmonary hypertension defined by mean pulmonary arterial pressure in children with left-to-right shunt congenital heart disease.
Article in Quantitative imaging in medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The computed tomography (CT)-derived main pulmonary artery-to-ascending aorta diameter ratio (MPA/AA) may identify pulmonary hypertension (PH). In left-to-right (L-R) shunt congenital heart disease (CHD), pulmonary overcirculation may enlarge the pulmonary artery without elevated mean pulmonary arterial pressure (mPAP), complicating threshold interpretation. We evaluated MPA/AA for mPAP-defined PH using right heart catheterization (RHC) and derived upper reference limits in RHC-negative children. Methods: Among 231 eligible children who underwent CT and RHC within 3 months, the primary diagnostic analysis was performed in 164 children with L-R shunt CHD. A heterogeneous non-L-R cardiovascular cohort (n=67) was used only to assess model transportability. Disease-context upper reference limits were estimated in 109 children without mPAP-defined PH on RHC. Results: In the primary cohort, median MPA/AA was higher in children with mPAP-defined PH than in those without it (1.56 Conclusions: In children with L-R shunt CHD, CT-derived MPA/AA adds useful information for identifying mPAP-defined PH on clinically indicated CT, but it does not replace RHC or justify CT screening.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.